Evolent Health (EVH) Total Debt (2016 - 2026)

Evolent Health's Total Debt history runs 11 years deep, the most recent figure standing at $973.5 million for Q1 2026.

• On a quarterly basis, Total Debt rose 18.82% year-over-year to $973.5 million in Q1 2026; TTM through Mar 2026 was $973.5 million, a 18.82% increase from a year earlier, with the FY2025 full-year figure at $970.5 million, up 46.61% from the prior year.
• Total Debt was little changed at $973.5 million in Q1 2026 per EVH's latest filing, from $970.5 million in the prior quarter.
• Across five years, Total Debt topped out at $1.1 billion in Q3 2025 and bottomed at $282.6 million in Q1 2022.
• The 5-year median for Total Debt is $600.9 million (2023), against an average of $644.5 million.
• Across the five-year window, Total Debt soared 123.74% in 2023 and fell 5.44% in 2024, its largest moves.
• Year by year, Total Debt stood at $413.0 million in 2022, then soared by 44.57% to $597.0 million in 2023, then increased by 10.88% to $662.0 million in 2024, then jumped by 46.61% to $970.5 million in 2025, then grew by 0.3% to $973.5 million in 2026.
• Per Business Quant, the three latest EVH Total Debt figures stand at $973.5 million (Q1 2026), $970.5 million (Q4 2025), and $1.1 billion (Q3 2025).